DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Schneeweiss A. Chia S. Hickish T. et al.
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).

Ann Oncol 2013;
24: 2278-2284

Download Bibliographical Data

Access:
Access: